Eylea (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema

TARRYTOWN, N.Y. , July 29, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA A Injection for the treatment of Diabetic Macular Edema .

http://ift.tt/1uJ3Lvw?